A group of hemp/CBD purveyors have teamed up with a clinical research firm to conduct a large scale study to provide the safety data that the US Food and Drug Administration says it lacks.
As Americans begin to emerge from quarantine and many cities begin the process of getting back to ‘normal,’ the FTC continues to keep an eye on companies making unsupported coronavirus claims.
The prevalence of virus-treatment claims in the marketplace has made for both heightened enforcement from federal regulators and calls for even more action from an advocacy group regarding products sold on Amazon.
The FDA says it has made “substantial progress” in forging a regulatory path for ingestible CBD products, but has given no indication of when it might provide food and supplement makers with more clarity.
A recent warning letter to a Colorado dietary supplement formulator has put front and center FDA’s determination that CBD should not be a constituent of dietary supplements.
The Natural Products Association (NPA) is calling for the US Food and Drug Administration to use import alerts to stop nutritional supplements that fail to comply with New Dietary Ingredient (NDI) regulations.
A judge has approved a permanent injunction order against the principals of a dietary supplement company who allegedly repeatedly ignored FDA warnings and inspection findings on illegal disease claims and other violations.
The Federal Trade Commission continues to be vigilant in policing health-related claims, after announcing over 22,580 refund checks would be mailed this week to consumers nationwide.
A new stakeholder group has come together to push for quality and transparency in the dietary supplement industry. Called the Dietary Supplement Quality Collaborative (DSQC), the group published a policy paper recently as part of its public debut.
Both local Chinese and foreign infant nutrition brands in China are urged to “push hard on safety cues and messages” in light of the recent infant nutrition scandal happening in the country, according to an industry expert.
The Federal Trade Commission has sent out another round of warning letters to 50 more marketers nationwide, most of which are labeled as dietary supplements or Chinese herbs.
The ongoing CBD regulatory logjam has stunted the development of responsible, informative health claims for these products. I’ve speculated in these pages before that this will lead consumers to make it up as they go along. Two new studies seem to confirm...
Speaking via video, Michael McGuffin, president of the American Herbal Products Association (AHPA), discussed a range of issues, from new supplement users sticking with the products, voicing support for recent FDA/FTC actions against egregious drug claims,...
The Federal Trade Commission just announced it is issuing refund checks totaling over $8.5 million to consumers defrauded by misleading claims on weight loss products an erectile dysfunction product in a case dating back to 2004.
The Food and Drug Administration (FDA) may have suspended all routine plant inspections, but dietary supplement producers are still expected to remain in compliance. In the meantime, the Federal Trade Commission has sent another 37 warning letters over...
Network marketing giant Herbalife has announced an agreement in principle with US authorities over a bribery scandal in China. The reported pact, which includes a $123 million fine, was part of the company’s first quarter earnings report, which came...
The Organic Trade Association is calling on the US Department of Agriculture to help ease mounting pressure on the organic supply chain posed by the ongoing coronavirus pandemic by increasing flexibility for inspections and the disbursement of funds related...
Alkemist Labs' CEO Elan Sudberg says he's seen evidence that some ingredient suppliers and marketing companies have been altering valid lab reports and using those falsified reports to promote their products.
Supplement manufacturer NOW reports that among CoQ10 and SAMe products it purchased recently on Amazon and subjected to analytical testing, only a few came close to meeting label claim for the amount of active ingredients, while most had little or none...
The Council for Responsible Nutrition has announced that a program it had supported at the National Advertising Division will end as the major funding source has been exhausted. But both CRN and NAD said the information contained in the more than 350...
A new survey out by the Natural Products Association (NPA) zeros in on the natural products industry and offers some insight into what the Paycheck Protection Program (PPP) process entails.
The state of Texas has proposed rules for consumable hemp products that specify processing, testing, labeling and registration requirements. While the rules are characterized as reasonable and well thought out, they represent another patch in a state-by-state...
The GMP Starter Kit aims to help guide brands through current Good Manufacturing Practices (cGMP) regulations and FDA compliance for nutritional and dietary supplement brands.
Some producers of essential oils have thrown their hats into the coronavirus claims ring, according to recent warning letters from the US Food and Drug Administration and the Federal Trade Commission.
Marketers of natural products need to be on their best behavior during this pandemic crisis as regulatory authorities comb through every aspect of a company’s marketing to look for disease claims, an attorney says.
The US Federal Trade Commission has sent 10 warning letters to network marketing companies whose participants it alleges have been making illegal COVID-19 treatment claims and earnings claims related to the pandemic crisis.
The last coronavirus relief package that was meant to ease the loan process for smaller supplement firms was largely deemed a disappointment by many. Now a new deal has been struck in the Senate, with the House expected to vote as soon as Thursday.
The State of Virginia has passed a law defining hemp extracts as an approved food. The law also allows a more liberal amount of THC in these products during the growth phase than does the federal description of industrial hemp.
Verbiage contained in a revised stay at home order issued by Colorado Gov. Jared Polis has led to the closure of some dietary supplement retailers in the state. It’s the second state after Nevada where such actions have been taken.
Health Canada has reiterated its stance that changes to product labels due to reclassification of species within the old Lactobacillus genus should occur within three years of changes to its monograph.
A group of trade associations has asked the IRS to allow the use of tax advantaged medical savings accounts to be used for the purchase of dietary supplements, a move that the group says could support consumers’ health as well as boost the economy.
Like many taking their work online during the coronavirus pandemic, antidoping officials who collect urine and blood samples from athletes are conducting their work over Zoom and FaceTime.
After years in the making, the taxonomic changes to the genus Lactobacillus have been published. The changes have significant impacts on many areas, from labeling to scientific publications and IP.
There is currently no cure for coronavirus, however, that hasn’t stopped companies from preying on consumers’ fears, as a new raft of FDA warning letters makes clear.
The sad news came this week of the death of a young girl who started a movement, one which has exposed again the built-in strains of how the dietary supplement market is regulated in the United States.
The US Food and Drug Administration has issued an additional six warning letters in recent days on coronavirus claims. The letters coincide with an industry coalition raising a red flag on the growing flood of such claims on dietary supplement-type products.
A coalition of dietary supplement industry trade associations have come out in support of FDA actions against fraudulent coronavirus treatment claims and have urged retailers to not stock products with such claims on their labels.
A wide ranging recall of products made by a New York-based contract manufacturer holds lessons supplement firms can use to avoid similar problems in the future, experts say.
The US Food and Drug Administration has issued another warning letter on COVID-19 claims. This one was issued to a Nevada company marketing CBD products.
Industry experts have slammed statements made in a recent JAMA Viewpoint that called for probiotics to be regulated to the same standard as drugs, and decried the “paucity of high-quality data supporting the value of probiotics”.
If only social distancing could stop the spread of misinformation. A prominent natural products chemist shares four steps on differentiating the real from the fake.
A new federal government update on who may be considered essential workers now specifically includes employees of dietary supplement manufacturing and sales operations. Trade groups said it’s now up to industry to make sure that is reflected in local...
The National Advertising Division has directed Church & Dwight to stop making a claim of better absorption on its line of gummy vitamins. The company has responded by appealing the decision to a review board.
The $2 trillion stimulus packaged passed unanimously by the US Senate this morning will have important implications for the dietary supplement industry that may help companies survive the worst of the coronavirus crisis impacts.
Dietary supplement companies may store adverse event reports and submit them after the present crisis is past, the US Food and Drug Administration said recently.
Synthetic astaxanthin product developer Cardax has released a white paper and reportedly filed a patent application on the ingredient’s antiviral properties and in publicizing the fact has treaded on the disease claim line according to legal experts.
In light of the ongoing novel Coronavirus (COVID19) public health emergency, IPA World Congress + Probiota Americas has been postponed until November 16-18, 2020 at the Crystal Gateway Marriott Hotel, Washington DC.
